Intravenous lacosamide for acute repetitive seizures and convulsive status epilepticus in critically ill children
Epilepsia Open · 2024
DOI: 10.1002/epi4.13047 ↗Kurz gefasst
Fachartikel in der Zeitschrift Epilepsia Open, 2024. Verfasst von Man-Ru Hsiao und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Chang Gung Memorial Hospital, Taoyuan, Taiwan. Hauptthemen laut MEDLINE: Lacosamide, Status Epilepticus, Critical Illness, Anticonvulsants. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Chang Gung Memorial Hospital, Linkou.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Objective
Acute repetitive seizures and convulsive status epilepticus are common neurological emergencies in critically ill children. The aim of the study was to evaluate the effectiveness and safety of intravenous lacosamide in critically ill children with acute repetitive seizures and convulsive status epilepticus.
Methods
This retrospective study included children who received intravenous lacosamide for acute repetitive seizures or convulsive status epilepticus from October 2017 to September 2022 and were admitted to the pediatric intensive care unit at a tertiary medical center. Children who were newly started on intravenous lacosamide were included and divided into two groups: (a) previously healthy, and (b) history of epilepsy and receiving antiseizure medications. Efficacy was defined as the cessation of seizures within 72 h of administering lacosamide. Adverse effects were defined using predefined criteria, and most were evaluated during the first 7 days.
Results
Sixty‐seven children were enrolled, including 25 (37.3%) girls and 42 (62.7%) boys with a mean age of 7.20 ± 5.66 years. Among them, 30 (44.8%) had acute repetitive seizures, and 37 (55.2%) had convulsive status epilepticus. The seizure types were focal onset ( n = 34, 50.7%), generalized onset ( n = 27, 40.3%), and mixed type ( n = 6, 9.0%). In the previously healthy group, 9 patients had acute repetitive seizures and 23 had convulsive status epilepticus, and the rates of seizure cessation when lacosamide was used as the first to fourth choice of antiseizure medication were 100.0%, 85.7%, 40.0%, and 50.0%, respectively, compared to 73.7%, 54.5%, 100.0%, and 0.0% in the patients with epilepsy (21 had acute repetitive seizures and 14 had convulsive status epilepticus). Sixteen (23.9%) patients developed bradycardia and 1 (1.5%) patient developed a rash. Significance The early use of intravenous lacosamide was effective with acceptable side effects in treating acute repetitive seizures and convulsive status epilepticus in critically ill children, including young infants and children less than 4 years old and those with different etiologies. Plain Language Summary Acute repetitive seizures and convulsive status epilepticus are common neurological emergencies in pediatric intensive care units (PICUs), traditional intravenous antiseizure medications (ASMs) include phenytoin, valproic acid, levetiracetam, and phenobarbital. In this study, we categorized patients based on their epilepsy history and different etiologies. We observed that early use of lacosamide, even in young infants, demonstrated good efficacy and safety.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy, Chang Gung Memorial Hospital, Taoyuan, Taiwan.
- Department of Long Term Care, Hsin Sheng Junior College of Medical Care and Management, Taoyuan, Taiwan.
- Division of Pediatric Critical Care Medicine and Pediatric Neurocritical Care Center, Department of Pediatrics, Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Taoyuan, Taiwan.
- Division of Pediatric Neurology, Department of Pediatrics, Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Taoyuan, Taiwan.
ORCID-Profile: Man-Ru Hsiao, Jainn-Jim Lin
Förderung
- Chang Gung Memorial Hospital, Linkou
Zitieren
APA
Hsiao, M. R., Tsai, T. C., Hsia, S. H., Chan, O. W., Lee, E. P., Lin, J. J., & Lin, K. L. (2024). Intravenous lacosamide for acute repetitive seizures and convulsive status epilepticus in critically ill children. Epilepsia Open. https://doi.org/10.1002/epi4.13047
Vancouver
Hsiao MR, Tsai TC, Hsia SH, Chan OW, Lee EP, Lin JJ, et al. Intravenous lacosamide for acute repetitive seizures and convulsive status epilepticus in critically ill children. Epilepsia Open. 2024. doi:10.1002/epi4.13047
BibTeX
@article{Hsiao2024,
author = {Hsiao, Man-Ru and Tsai, Tzu-Cheng and Hsia, Shao-Hsuan and Chan, Oi-Wa and Lee, En-Pei and Lin, Jainn-Jim and Lin, Kuang-Lin},
title = {Intravenous lacosamide for acute repetitive seizures and convulsive status epilepticus in critically ill children},
journal = {Epilepsia Open},
year = {2024},
doi = {10.1002/epi4.13047}
}
EUVIMED